ADHD Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been clinically diagnosed with ADHD according to the DSM-5 diagnostic guidelines
- Children aged 6 to 12 years old, of any gender
- Children who are right-handed
- Children of Han nationality, or children born within a Han nationality community
- Children whose ADHD symptoms have been present for more than 6 months
- Children whose intelligence score, as measured by the Wechsler children's intelligence test, is 70 or above
- Children whose parent or legal guardian has agreed to participate and has signed a consent form
Who may not be able to join:
- Children who also have a mental health condition such as anxiety or depression
- Children who have a widespread developmental disorder or other neurodevelopmental conditions
- Children who have a serious condition affecting major organs such as the heart or lungs
- Children who have epilepsy or a tic disorder
- Children who are unable to tolerate or cooperate with rTMS treatment (a type of non-invasive brain stimulation therapy)
- Children who have taken certain medications — including psychoactive drugs, antipsychotics, antidepressants, or mood stabilisers — in the 3 months before enrolling or during the treatment period; or children who have used standard first-line ADHD medications (other than a low dose of Atomoxetine at 1.2–1.4 mg/kg per day) (confirm with trial site)
- Children who have metal or electronic devices implanted in their body, such as a pacemaker (devices in the mouth are excluded from this rule)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Shaohua Hu, Dr, Zhejiang University
Phone: 0571-87235987
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
ADHD-RS
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.